Already have an account? Log in
SEQUORA’s Testosterone Pen contains a 3ml solution at a concentration of 200mg/ml, giving 600mg of testosterone compound in total. Supplied in a prefilled pen format, it provides a prepared TRT dose without the hassle of vials and insulin syringes. The active Testosterone compound is Testosterone Cypionate.
The pen’s total content does not indicate a prescribed dose, treatment duration or amount delivered per device setting. These depend on the formulation, device specifications and for medical treatment, an individual prescription.
All of our products are third party laboratory tested to ensure both purity and verification of the peptide itself.
A prefilled pen holds the solution within the device, removing the need to draw it from a vial into a separate syringe. SEQUORA’s TRT Pen contained 600mg of Testosterone Cypionate mixed with MCT Oil, this means one SEQUORA TRT Pen provides 4x 150mg injections or 8x 75mg injections.
This means all you need to do is your pre-injection hygiene and swap a needle tip and you’re done!
Please note: with a TRT pen the only option is subcutaneous injection.
Due to the set “clicks” and units on an injector pen, customers find it to be a lot more accurate when it comes to dosing your Testosterone injections.
SEQUORA TRT pens use disposable needle tips, although some devices have an integrated needle. Our TRT pens with replaceable needles require a new compatible sterile needle for each injection. We supply extra needle tips with every pen and can supply more if required.
We wouldn’t advise refridgerating your pen as it can cause the Testosterone Cypionate to crystalise or “Crash” which then requires the cartridge to be submerged in warm water for 2-3 minutes. After that you can swirl the cartridge around and the oil will return to its injectable state.
Product information, handling and safety
What Temperature should I store my Testosterone Replacement Therapy at?
What are the best practices for using Testosterone Replacement Therapy safely?
The documentation behind Testosterone Replacement Therapy and it's uses
Upon delivery store in a room temperature, ideally dark place.
Avoid dropping or heavy-handling of your SEQUORA TRT Pen.
Follow storage instructions to avoid allowing the Testosterone Cypionate to crash or crystalise.
Your TRT Pen will be shipped in temperature sensitive packaging to avoid this, especially during cold months.
Your SEQUORA Testosterone Replacement Therapy Pen will last 3 months from the date of manufacture providing you follow the storage instructions provided.
If your product does crash or crystalise, the vial end of the pen can be slowly swirled in warm water to restore it.
Before handling your TRT pen, needles and injection material, ensure your area is clean and clear.
Wash your hands with warm water and soap and allow to dry fully before handling any SEQUORA products to prevent cross contamination or infection risks.
If at any point the cleanliness of your injection or environment is compromised, restart this step.
Never re-use or share needles/syringes. Ensure your needle tips or syringe is sealed and new before injection.
Before using your SEQUORA TRT Pen, use an alcohol wipe and wipe the tip of the cartridge after removing the lid to the pen.
If at any point you touch something unhygienic or potentially dirty, re-wash your hands and use new equipment.
Ensure that your needle tips, syringes and vials are safely disposed of post-use.
This could mean a sharps bin or safe container. Most needle tips and syringes have removable tops that can be replaced onto the used needle.
Try to keep your injection site clean for atleast 30 minutes post-injection to prevent infection risks.
Testosterone cypionate is an injectable testosterone medicine used to treat diagnosed testosterone deficiency. It can cause side effects, although not everyone experiences them. Risks depend on the dose, blood testosterone levels, formulation and individual medical history.
Recognised side effects
Raised red blood cell levels
Testosterone cypionate can increase haemoglobin and haematocrit, sometimes causing erythrocytosis, an excessive rise in red blood cells. This may occur without symptoms and requires blood monitoring. Your prescriber may adjust the dose, change the formulation or temporarily withhold treatment.
Blood pressure, fluid retention and blood clots
Testosterone can increase blood pressure. Fluid retention can be particularly important in people with heart, kidney or liver disease. Blood clots in the legs or lungs have also been reported with testosterone products.
Cardiovascular safety findings from testosterone gel trials cannot automatically be applied to every testosterone cypionate regimen or blood testosterone level.
Fertility and testicular changes
Testosterone cypionate suppresses the hormonal signals that support natural testosterone and sperm production. Sperm counts may fall substantially or become undetectable, and testicular size may decrease. Recovery after stopping varies and is not guaranteed within a particular timeframe. TRT is not reliable contraception.
Sleep apnoea and urinary symptoms
Testosterone may worsen sleep-disordered breathing in susceptible people. Report louder snoring, breathing pauses or increased daytime sleepiness.
Report new or worsening difficulty passing urine. Prostate assessment and PSA monitoring should be discussed according to age, medical history and individual risk.
Injection and ingredient reactions
Reactions may relate to testosterone, the carrier oil, preservatives or administration technique. Tell your prescriber about known allergies. Increasing pain, spreading redness, warmth, swelling, discharge or fever requires assessment for possible infection.
When to seek emergency help
Call 999 for chest pain, sudden breathlessness, coughing up blood, collapse, signs of stroke or swelling of the lips, tongue or throat with breathing difficulty. Seek urgent assessment for a painful, swollen leg or inability to pass urine.
Go to A&E immediately for an erection lasting more than 3 to 4 hours. Seek urgent advice sooner if it is painful or not resolving.
About this information
This information concerns medically prescribed testosterone cypionate replacement therapy. It does not replace the product leaflet, your prescriber’s advice or your individual monitoring plan.
The main ways to reduce risks during testosterone cypionate treatment are accurate administration, appropriate blood monitoring and clinician-led adjustments. HCG may have a role in selected patients, but it is not a general antidote to testosterone side effects.
Follow the prescribed regimen
Monitor blood levels consistently
Raised haematocrit
A haematocrit above 54% requires prompt prescriber review. Guidelines generally recommend withholding testosterone, investigating contributing factors such as low oxygen levels or sleep apnoea and reconsidering treatment before restarting.
Do not use aspirin, excessive fluid intake or repeated blood donation as a substitute for reviewing the cause. Therapeutic blood removal should be medically directed.
Acne, breast tenderness and fluctuating symptoms
HCG: its possible role alongside TRT
Human chorionic gonadotropin (HCG) acts similarly to luteinising hormone and stimulates testosterone production within the testes. A specialist may consider it when discussing fertility preservation or testicular function during TRT. Its use alongside testosterone for this purpose may be off-label, depending on the product and jurisdiction.
Small studies suggest that HCG can maintain intratesticular testosterone during testosterone-induced hormonal suppression. A small retrospective study also reported maintained semen parameters in men receiving testosterone with HCG. These findings are encouraging but do not guarantee preserved fertility or establish one regimen suitable for everyone.
Using HCG safely
If conception is a current goal, specialist review is important. Treatment may involve replacing testosterone with a fertility-focused approach rather than simply adding HCG. Some patients need additional fertility treatment.
Blood pressure and sleep apnoea
Injection safety
When to get help
Contact your prescriber for persistent side effects rather than adding medicines or supplements yourself. Call 999 for chest pain, sudden breathlessness, stroke symptoms, collapse or a severe allergic reaction.
About this information
This guidance supports medically prescribed testosterone cypionate treatment. HCG decisions require individual assessment and follow-up; it is not necessary or appropriate for every person receiving TRT.
SEQUORA Testosterone Replacement Therapy Pen dosages below are for guidance only and are not a substitute for following your blood work, any TRT should be undertaken with medical supervision or from a prescriber.
Calculation basis: 600 mg testosterone cypionate in a final volume of 3 ml, giving 200 mg/ml.
| Total weekly dose | Injection frequency | Amount per injection | Liquid volume per injection | 200mg/ml Pen dial setting |
|---|---|---|---|---|
| 100 mg | Twice weekly | 50 mg | 0.25 ml | 25 |
| 120 mg | Twice weekly | 60 mg | 0.30 ml | 30 |
| 148 mg | Twice weekly | 74 mg | 0.370 ml | 37 |
Understanding the figures
Pen settings apply to each individual injection, not the weekly total. These calculations apply only to a concentration of 200 mg/ml and the SEQUORA TRT Pen delivering 0.01 ml per dial unit.
Device accuracy and prescribed treatment
The SEQUORA Pen cannot accurately dose 75mg in one injection, it has been rounded down to 37 from 37.5 meaning your liquid volume will be 370ml.